DexCom Inc (DXCM)
133.56
+2.05
(+1.56%)
USD |
NASDAQ |
Apr 23, 11:55
DexCom Enterprise Value: 50.41B for April 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 50.41B |
| April 19, 2024 | 50.10B |
| April 18, 2024 | 51.48B |
| April 17, 2024 | 51.32B |
| April 16, 2024 | 52.34B |
| April 15, 2024 | 51.59B |
| April 12, 2024 | 52.19B |
| April 11, 2024 | 53.54B |
| April 10, 2024 | 53.81B |
| April 09, 2024 | 53.86B |
| April 08, 2024 | 53.66B |
| April 05, 2024 | 53.27B |
| April 04, 2024 | 51.11B |
| April 03, 2024 | 53.11B |
| April 02, 2024 | 52.39B |
| April 01, 2024 | 52.89B |
| March 28, 2024 | 53.18B |
| March 27, 2024 | 53.48B |
| March 26, 2024 | 53.66B |
| March 25, 2024 | 53.72B |
| March 22, 2024 | 51.05B |
| March 21, 2024 | 51.14B |
| March 20, 2024 | 50.80B |
| March 19, 2024 | 51.43B |
| March 18, 2024 | 51.65B |
| Date | Value |
|---|---|
| March 15, 2024 | 50.00B |
| March 14, 2024 | 49.63B |
| March 13, 2024 | 50.47B |
| March 12, 2024 | 51.90B |
| March 11, 2024 | 51.00B |
| March 08, 2024 | 51.85B |
| March 07, 2024 | 51.08B |
| March 06, 2024 | 51.26B |
| March 05, 2024 | 46.66B |
| March 04, 2024 | 46.86B |
| March 01, 2024 | 46.64B |
| February 29, 2024 | 44.07B |
| February 28, 2024 | 43.74B |
| February 27, 2024 | 44.17B |
| February 26, 2024 | 44.50B |
| February 23, 2024 | 44.53B |
| February 22, 2024 | 45.01B |
| February 21, 2024 | 44.58B |
| February 20, 2024 | 45.15B |
| February 16, 2024 | 44.83B |
| February 15, 2024 | 45.08B |
| February 14, 2024 | 44.72B |
| February 13, 2024 | 44.83B |
| February 12, 2024 | 45.36B |
| February 09, 2024 | 46.15B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
10.09B
Minimum
May 23 2019
62.13B
Maximum
Nov 17 2021
36.15B
Average
37.82B
Median
Oct 24 2022
Enterprise Value Benchmarks
| Abbott Laboratories | 193.41B |
| Edwards Lifesciences Corp | 51.31B |
| Intuitive Surgical Inc | 126.16B |
| Cardinal Health Inc | 25.15B |
| Insulet Corp | 12.21B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 256.30M |
| Revenue (Quarterly) | 1.034B |
| Total Expenses (Quarterly) | 817.60M |
| EPS Diluted (Quarterly) | 0.62 |
| Gross Profit Margin (Quarterly) | 63.47% |
| Profit Margin (Quarterly) | 24.78% |
| Earnings Yield | 0.98% |
| Operating Earnings Yield | 1.06% |
| Normalized Earnings Yield | 0.9808 |